{"id": "article-24161_0", "title": "Left Ventricular Failure -- Continuing Education Activity", "content": "Left heart failure occurs when there is dysfunction of the left ventricle, resulting insufficient delivery of blood to vital organs. Left ventricular failure can be further subdivided into heart failure with preserved ejection fraction (HFpEF) with ejection fraction over 50 percent, heart failure with reduced ejection fraction (HFrEF) with ejection fraction less than 40 percent, or heart failure with mid-range ejection fraction, with ejection fraction between 41 and 49 percent. This activity describes the evaluation and management of left heart failure and highlights the role of the interprofessional team in improving care for affected patients.", "contents": "Left Ventricular Failure -- Continuing Education Activity. Left heart failure occurs when there is dysfunction of the left ventricle, resulting insufficient delivery of blood to vital organs. Left ventricular failure can be further subdivided into heart failure with preserved ejection fraction (HFpEF) with ejection fraction over 50 percent, heart failure with reduced ejection fraction (HFrEF) with ejection fraction less than 40 percent, or heart failure with mid-range ejection fraction, with ejection fraction between 41 and 49 percent. This activity describes the evaluation and management of left heart failure and highlights the role of the interprofessional team in improving care for affected patients."}
{"id": "article-24161_1", "title": "Left Ventricular Failure -- Continuing Education Activity", "content": "Objectives: Describe the risk factors for developing left heart failure. Review the clinical manifestations of left heart failure. Identify the latest treatment options for left heart failure. Explain the importance of improving care coordination amongst interprofessional team members to decrease mortality of patients with left heart failure. Access free multiple choice questions on this topic.", "contents": "Left Ventricular Failure -- Continuing Education Activity. Objectives: Describe the risk factors for developing left heart failure. Review the clinical manifestations of left heart failure. Identify the latest treatment options for left heart failure. Explain the importance of improving care coordination amongst interprofessional team members to decrease mortality of patients with left heart failure. Access free multiple choice questions on this topic."}
{"id": "article-24161_2", "title": "Left Ventricular Failure -- Introduction", "content": "The heart is comprised of the pericardium, myocardium, and endocardium. Pathology in any of those structures can lead to heart failure.\u00a0Left ventricular failure occurs when there is dysfunction of the left ventricle\u00a0causing insufficient delivery of blood to vital body organs.\u00a0Left ventricular failure can further subdivide into heart failure with preserved ejection fraction (HFpEF with EF over 50%), heart failure with reduced ejection fraction (HFrEF with EF less than 40%), or heart failure with mid-range ejection fraction (EF between 41 and 49 percent).", "contents": "Left Ventricular Failure -- Introduction. The heart is comprised of the pericardium, myocardium, and endocardium. Pathology in any of those structures can lead to heart failure.\u00a0Left ventricular failure occurs when there is dysfunction of the left ventricle\u00a0causing insufficient delivery of blood to vital body organs.\u00a0Left ventricular failure can further subdivide into heart failure with preserved ejection fraction (HFpEF with EF over 50%), heart failure with reduced ejection fraction (HFrEF with EF less than 40%), or heart failure with mid-range ejection fraction (EF between 41 and 49 percent)."}
{"id": "article-24161_3", "title": "Left Ventricular Failure -- Etiology", "content": "The most common etiologies of left heart failure are coronary artery disease and hypertension. The latter can cause left heart failure through left ventricular hypertrophy (leading to HFpEF), and also serves as a risk factor for coronary artery disease (which can lead\u00a0to HFrEF). Diabetes, smoking, obesity, male gender,\u00a0and\u00a0a sedentary lifestyle\u00a0are also considered risk factors. [1] [2] [3] Many of these causes are preventable, and as such\u00a0risk factor control remains of extreme importance in preventing heart failure. [4]", "contents": "Left Ventricular Failure -- Etiology. The most common etiologies of left heart failure are coronary artery disease and hypertension. The latter can cause left heart failure through left ventricular hypertrophy (leading to HFpEF), and also serves as a risk factor for coronary artery disease (which can lead\u00a0to HFrEF). Diabetes, smoking, obesity, male gender,\u00a0and\u00a0a sedentary lifestyle\u00a0are also considered risk factors. [1] [2] [3] Many of these causes are preventable, and as such\u00a0risk factor control remains of extreme importance in preventing heart failure. [4]"}
{"id": "article-24161_4", "title": "Left Ventricular Failure -- Epidemiology", "content": "Heart failure is more prevalent and has a higher incidence in the elderly population. Approximately 5.7 million people in the United States have diagnosed heart failure. The incidence\u00a0is around 10 per 1000 in people over 65. [5] [6] Approximately 50% of all patients with heart failure are considered to have HFrEF; this diagnosis is becoming more prevalent with time. [7] [8] HFpEF, as opposed to\u00a0HFrEF, is more common in women (79% versus 49%) and also tends to affect\u00a0an older population. [9]", "contents": "Left Ventricular Failure -- Epidemiology. Heart failure is more prevalent and has a higher incidence in the elderly population. Approximately 5.7 million people in the United States have diagnosed heart failure. The incidence\u00a0is around 10 per 1000 in people over 65. [5] [6] Approximately 50% of all patients with heart failure are considered to have HFrEF; this diagnosis is becoming more prevalent with time. [7] [8] HFpEF, as opposed to\u00a0HFrEF, is more common in women (79% versus 49%) and also tends to affect\u00a0an older population. [9]"}
{"id": "article-24161_5", "title": "Left Ventricular Failure -- Pathophysiology", "content": "Multiple mechanisms can lead to left heart failure. Chronic or poorly controlled hypertension causes increased afterload and therefore\u00a0increased cardiac\u00a0workload, which can lead to hypertrophy of the left ventricle. Initially, this hypertrophy serves as a compensatory mechanism and can help maintain cardiac output, but long-term can\u00a0inhibit relaxation of the myocardium leading to impaired cardiac filling and decrease left ventricular output. Coronary arterial disease causes direct ischemic damage to the myocardium, leading to remodeling and scar formation, which decreases contractility and\u00a0cardiac output. Arrhythmias can cause remodeling, but in general,\u00a0decrease cardiac output by impaired ventricular filling and decreased ventricular relaxation.\u00a0Cardiomyopathies encompass a diverse pathologic spectrum and have variable mechanisms causing cardiac dysfunction. [10]", "contents": "Left Ventricular Failure -- Pathophysiology. Multiple mechanisms can lead to left heart failure. Chronic or poorly controlled hypertension causes increased afterload and therefore\u00a0increased cardiac\u00a0workload, which can lead to hypertrophy of the left ventricle. Initially, this hypertrophy serves as a compensatory mechanism and can help maintain cardiac output, but long-term can\u00a0inhibit relaxation of the myocardium leading to impaired cardiac filling and decrease left ventricular output. Coronary arterial disease causes direct ischemic damage to the myocardium, leading to remodeling and scar formation, which decreases contractility and\u00a0cardiac output. Arrhythmias can cause remodeling, but in general,\u00a0decrease cardiac output by impaired ventricular filling and decreased ventricular relaxation.\u00a0Cardiomyopathies encompass a diverse pathologic spectrum and have variable mechanisms causing cardiac dysfunction. [10]"}
{"id": "article-24161_6", "title": "Left Ventricular Failure -- History and Physical", "content": "Patients with left heart failure may present with complaints of shortness of breath (often on exertion, a sensitivity of 89%), orthopnea (a specificity of 89%), paroxysmal nocturnal dyspnea and/or symptoms of volume overload (e.g., leg swelling, weight gain, increased abdominal girth, or right upper quadrant pain due to liver congestion). [11] Interestingly, some patients with advanced disease might experience weight loss, referred to as \"cardiac cachexia.\" [12] On physical exam, the most common signs encountered are:", "contents": "Left Ventricular Failure -- History and Physical. Patients with left heart failure may present with complaints of shortness of breath (often on exertion, a sensitivity of 89%), orthopnea (a specificity of 89%), paroxysmal nocturnal dyspnea and/or symptoms of volume overload (e.g., leg swelling, weight gain, increased abdominal girth, or right upper quadrant pain due to liver congestion). [11] Interestingly, some patients with advanced disease might experience weight loss, referred to as \"cardiac cachexia.\" [12] On physical exam, the most common signs encountered are:"}
{"id": "article-24161_7", "title": "Left Ventricular Failure -- History and Physical", "content": "Rales on lung auscultation indicative of pulmonary edema Decreased breath sounds on lung auscultation suggestive of pleural effusion S3 gallop\u00a0on heart auscultation indicative of elevated left ventricular end-diastolic pressure Point of maximal impulse displaced laterally on palpation characteristic of increased heart size Jugular venous distention (jugular venous pressure over 8 cm of water) indicative of elevated right atrial pressure Positive hepatojugular reflux (exerting manual pressure on the congested liver causing increased jugular venous pressures) Increased abdominal girth due to ascites Swelling of the scrotum Low blood pressure and rapid heart rate can occur in severely decompensated failure\u00a0due to decreased cardiac output", "contents": "Left Ventricular Failure -- History and Physical. Rales on lung auscultation indicative of pulmonary edema Decreased breath sounds on lung auscultation suggestive of pleural effusion S3 gallop\u00a0on heart auscultation indicative of elevated left ventricular end-diastolic pressure Point of maximal impulse displaced laterally on palpation characteristic of increased heart size Jugular venous distention (jugular venous pressure over 8 cm of water) indicative of elevated right atrial pressure Positive hepatojugular reflux (exerting manual pressure on the congested liver causing increased jugular venous pressures) Increased abdominal girth due to ascites Swelling of the scrotum Low blood pressure and rapid heart rate can occur in severely decompensated failure\u00a0due to decreased cardiac output"}
{"id": "article-24161_8", "title": "Left Ventricular Failure -- Evaluation", "content": "The diagnosis of heart failure is clinical. However, several tests are available for further evaluation:", "contents": "Left Ventricular Failure -- Evaluation. The diagnosis of heart failure is clinical. However, several tests are available for further evaluation:"}
{"id": "article-24161_9", "title": "Left Ventricular Failure -- Evaluation", "content": "Laboratory tests:\u00a0brain natriuretic peptide (BNP) or NT-proBNP\u00a0may be the most helpful\u00a0as it can differentiate\u00a0acute\u00a0heart failure from other causes of shortness of breath.\u00a0However, this test lacks specificity, and a high level of this hormone is not diagnostic of acute heart failure. [11] [13] Other laboratory tests include troponin T (to detect myocardial infarction, although the levels may be high due to heart failure itself), complete blood count, basic metabolic panel (low\u00a0sodium, in particular,\u00a0indicates advanced disease)\u00a0and liver function tests (to detect liver\u00a0injury due to volume overload).", "contents": "Left Ventricular Failure -- Evaluation. Laboratory tests:\u00a0brain natriuretic peptide (BNP) or NT-proBNP\u00a0may be the most helpful\u00a0as it can differentiate\u00a0acute\u00a0heart failure from other causes of shortness of breath.\u00a0However, this test lacks specificity, and a high level of this hormone is not diagnostic of acute heart failure. [11] [13] Other laboratory tests include troponin T (to detect myocardial infarction, although the levels may be high due to heart failure itself), complete blood count, basic metabolic panel (low\u00a0sodium, in particular,\u00a0indicates advanced disease)\u00a0and liver function tests (to detect liver\u00a0injury due to volume overload)."}
{"id": "article-24161_10", "title": "Left Ventricular Failure -- Evaluation", "content": "Electrocardiography can show nonspecific findings, like ischemic changes, left ventricular hypertrophy, or arrhythmias.", "contents": "Left Ventricular Failure -- Evaluation. Electrocardiography can show nonspecific findings, like ischemic changes, left ventricular hypertrophy, or arrhythmias."}
{"id": "article-24161_11", "title": "Left Ventricular Failure -- Evaluation", "content": "Echocardiography can help distinguish HFrEF from HFpEF\u00a0by determining the\u00a0ejection fraction, and\u00a0diastolic left ventricular function can evaluate associated regional wall motion abnormalities that may\u00a0be suggestive of an\u00a0ischemic component,\u00a0as well as\u00a0valvular and pericardial pathologies.", "contents": "Left Ventricular Failure -- Evaluation. Echocardiography can help distinguish HFrEF from HFpEF\u00a0by determining the\u00a0ejection fraction, and\u00a0diastolic left ventricular function can evaluate associated regional wall motion abnormalities that may\u00a0be suggestive of an\u00a0ischemic component,\u00a0as well as\u00a0valvular and pericardial pathologies."}
{"id": "article-24161_12", "title": "Left Ventricular Failure -- Evaluation", "content": "Coronary angiography is indicated in patients with anginal symptoms and may also be indicated in patients with worsening heart failure symptoms. [14]", "contents": "Left Ventricular Failure -- Evaluation. Coronary angiography is indicated in patients with anginal symptoms and may also be indicated in patients with worsening heart failure symptoms. [14]"}
{"id": "article-24161_13", "title": "Left Ventricular Failure -- Treatment / Management", "content": "Patients should receive education on the importance of lifestyle modification for\u00a0improving the outcome of their disease. This includes reasonable salt consumption and avoidance of alcohol, nicotine, and recreational drugs.", "contents": "Left Ventricular Failure -- Treatment / Management. Patients should receive education on the importance of lifestyle modification for\u00a0improving the outcome of their disease. This includes reasonable salt consumption and avoidance of alcohol, nicotine, and recreational drugs."}
{"id": "article-24161_14", "title": "Left Ventricular Failure -- Treatment / Management", "content": "Treating the underlying cause is of extreme importance as some heart failure conditions may be reversible when the precipitating factors\u00a0are\u00a0addressed, like\u00a0cardiomyopathies induced by alcohol, tachycardia or ischemia. Tight control of blood pressure will also help prevent further deterioration. [15] Besides loop diuretics for volume overload, the pharmacologic treatment differs between HFrEF and HFpEF [16] [17] [18] : -For HFrEF, the mainstay of treatment is the combination of an angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) with a beta blocker (carvedilol, metoprolol or bisoprolol). If the patient remains symptomatic on a maximal dose of ACE inhibitor or ARB,\u00a0an angiotensin receptor-neprilysin inhibitor may be substituted. Other\u00a0medications include hydralazine, nitrates, mineralocorticoid receptor antagonists such as spironolactone, ivabradine, and digoxin (as a last resort). Nitrates in combination with hydralazine may be especially efficacious in African American patients. Digoxin, ivabradine and the diuretics have not been shown to offer any mortality benefit.", "contents": "Left Ventricular Failure -- Treatment / Management. Treating the underlying cause is of extreme importance as some heart failure conditions may be reversible when the precipitating factors\u00a0are\u00a0addressed, like\u00a0cardiomyopathies induced by alcohol, tachycardia or ischemia. Tight control of blood pressure will also help prevent further deterioration. [15] Besides loop diuretics for volume overload, the pharmacologic treatment differs between HFrEF and HFpEF [16] [17] [18] : -For HFrEF, the mainstay of treatment is the combination of an angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) with a beta blocker (carvedilol, metoprolol or bisoprolol). If the patient remains symptomatic on a maximal dose of ACE inhibitor or ARB,\u00a0an angiotensin receptor-neprilysin inhibitor may be substituted. Other\u00a0medications include hydralazine, nitrates, mineralocorticoid receptor antagonists such as spironolactone, ivabradine, and digoxin (as a last resort). Nitrates in combination with hydralazine may be especially efficacious in African American patients. Digoxin, ivabradine and the diuretics have not been shown to offer any mortality benefit."}
{"id": "article-24161_15", "title": "Left Ventricular Failure -- Treatment / Management", "content": "- For HFpEF, the treatment focuses on the underlying cause or contributing factors: control of blood pressure, revascularization if ischemic cardiomyopathy, and management of arrhythmias. A mineralocorticoid receptor antagonist may be beneficial in these patients.", "contents": "Left Ventricular Failure -- Treatment / Management. - For HFpEF, the treatment focuses on the underlying cause or contributing factors: control of blood pressure, revascularization if ischemic cardiomyopathy, and management of arrhythmias. A mineralocorticoid receptor antagonist may be beneficial in these patients."}
{"id": "article-24161_16", "title": "Left Ventricular Failure -- Treatment / Management", "content": "Severely symptomatic patients with an ejection fraction less than 35%\u00a0should obtain a referral for implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy (CRT) (depending on QRS width and the type of\u00a0intraventricular conduction delay) after medical optimization. In advanced cases,\u00a0mechanical circulatory assist devices such as an LVAD, continuous infusion of inotropic medications such as dobutamine or milrinone (which is still possible in the ambulatory setting), and cardiac transplantation are options.", "contents": "Left Ventricular Failure -- Treatment / Management. Severely symptomatic patients with an ejection fraction less than 35%\u00a0should obtain a referral for implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy (CRT) (depending on QRS width and the type of\u00a0intraventricular conduction delay) after medical optimization. In advanced cases,\u00a0mechanical circulatory assist devices such as an LVAD, continuous infusion of inotropic medications such as dobutamine or milrinone (which is still possible in the ambulatory setting), and cardiac transplantation are options."}
{"id": "article-24161_17", "title": "Left Ventricular Failure -- Differential Diagnosis", "content": "When approaching a patient with shortness of breath on exertion, a broad differential diagnosis exists. A patient with established left heart failure might have a concomitant disease that might contribute to the patient's presentation, and additional workup for other conditions is warranted in case of atypical presentations. Those conditions include other cardiovascular causes (like primary pulmonary hypertension), pulmonary causes (like chronic obstructive pulmonary disease and interstitial lung disease) and extra-cardiopulmonary causes (like anemia). Isolated lower limb edema is less likely heart failure, and other causes must be ruled out first, like venous insufficiency, cirrhosis, nephrotic syndrome, lymphedema and\u00a0thrombosis of the veins.", "contents": "Left Ventricular Failure -- Differential Diagnosis. When approaching a patient with shortness of breath on exertion, a broad differential diagnosis exists. A patient with established left heart failure might have a concomitant disease that might contribute to the patient's presentation, and additional workup for other conditions is warranted in case of atypical presentations. Those conditions include other cardiovascular causes (like primary pulmonary hypertension), pulmonary causes (like chronic obstructive pulmonary disease and interstitial lung disease) and extra-cardiopulmonary causes (like anemia). Isolated lower limb edema is less likely heart failure, and other causes must be ruled out first, like venous insufficiency, cirrhosis, nephrotic syndrome, lymphedema and\u00a0thrombosis of the veins."}
{"id": "article-24161_18", "title": "Left Ventricular Failure -- Staging", "content": "The \"2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart\u00a0failure in adults\" recommends a staging for heart failure.[ [19] Patients with stages A and B are those who are asymptomatic but are prone to develop heart failure\u00a0in the future, for example, diabetic\u00a0and hypertensive patients. Stage B differs from stage A by the presence of\u00a0a structural cardiac abnormality, like ventricular hypertrophy or systolic dysfunction, but again with no symptoms. Stage C and D patients include those who have ever experienced symptoms of heart failure. Stage D patients are those with severe heart failure\u00a0who require advanced treatment like mechanical support, around-the-clock inotropic agents and heart transplantation.Stage C and D patients can be further classified\u00a0based on the New York Heart Association (NYHA) Functional Classification:", "contents": "Left Ventricular Failure -- Staging. The \"2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart\u00a0failure in adults\" recommends a staging for heart failure.[ [19] Patients with stages A and B are those who are asymptomatic but are prone to develop heart failure\u00a0in the future, for example, diabetic\u00a0and hypertensive patients. Stage B differs from stage A by the presence of\u00a0a structural cardiac abnormality, like ventricular hypertrophy or systolic dysfunction, but again with no symptoms. Stage C and D patients include those who have ever experienced symptoms of heart failure. Stage D patients are those with severe heart failure\u00a0who require advanced treatment like mechanical support, around-the-clock inotropic agents and heart transplantation.Stage C and D patients can be further classified\u00a0based on the New York Heart Association (NYHA) Functional Classification:"}
{"id": "article-24161_19", "title": "Left Ventricular Failure -- Staging", "content": "Class I: symptoms not restricting daily activities. Class II:\u00a0symptoms occurring at moderate effort slightly restricting daily activities. Class III: symptoms occurring at minimal effort with significant restriction of daily activities. Class IV: debilitating symptoms are occurring at rest.", "contents": "Left Ventricular Failure -- Staging. Class I: symptoms not restricting daily activities. Class II:\u00a0symptoms occurring at moderate effort slightly restricting daily activities. Class III: symptoms occurring at minimal effort with significant restriction of daily activities. Class IV: debilitating symptoms are occurring at rest."}
{"id": "article-24161_20", "title": "Left Ventricular Failure -- Prognosis", "content": "The mortality rate in heart failure in 2008 was\u00a018.2 per 100,000 for males and 15.8 per\u00a0100,000 for females based on the \"Morbidity and Mortality: 2012\u00a0Chart Book on Cardiovascular, Lung and Blood Diseases\". Patients\u00a0with HFpEF have\u00a0been known to have a lower mortality rate than those with HFrEF. [20]", "contents": "Left Ventricular Failure -- Prognosis. The mortality rate in heart failure in 2008 was\u00a018.2 per 100,000 for males and 15.8 per\u00a0100,000 for females based on the \"Morbidity and Mortality: 2012\u00a0Chart Book on Cardiovascular, Lung and Blood Diseases\". Patients\u00a0with HFpEF have\u00a0been known to have a lower mortality rate than those with HFrEF. [20]"}
{"id": "article-24161_21", "title": "Left Ventricular Failure -- Prognosis", "content": "Multiple variables have associations with worse outcome in heart failure: male gender, advancing age, low ejection fraction, high\u00a0NYHA functional class, low hematocrit, and sodium levels, high brain natriuretic peptide,\u00a0low peak exercise oxygen uptake, wide QRS, renal failure, low blood pressure, elevated heart rate, and volume overload refractory to medical treatment. [19] [21]", "contents": "Left Ventricular Failure -- Prognosis. Multiple variables have associations with worse outcome in heart failure: male gender, advancing age, low ejection fraction, high\u00a0NYHA functional class, low hematocrit, and sodium levels, high brain natriuretic peptide,\u00a0low peak exercise oxygen uptake, wide QRS, renal failure, low blood pressure, elevated heart rate, and volume overload refractory to medical treatment. [19] [21]"}
{"id": "article-24161_22", "title": "Left Ventricular Failure -- Complications", "content": "Left heart failure can be complicated with severe volume overload leading to respiratory distress and anasarca as well as arrhythmias (tachyarrhythmias or bradyarrhythmias),\u00a0cardiogenic shock due to pump failure and death.\u00a0It was also reported that pulmonary embolism, acute coronary syndrome, cerebrovascular accidents and rupture of the myocardium are common causes of sudden death in patients with heart failure. [22] In addition to implantable cardioverter-defibrillators, several medications (stated above) reduce mortality in left heart failure and initiation of therapy should be as soon as indicated.", "contents": "Left Ventricular Failure -- Complications. Left heart failure can be complicated with severe volume overload leading to respiratory distress and anasarca as well as arrhythmias (tachyarrhythmias or bradyarrhythmias),\u00a0cardiogenic shock due to pump failure and death.\u00a0It was also reported that pulmonary embolism, acute coronary syndrome, cerebrovascular accidents and rupture of the myocardium are common causes of sudden death in patients with heart failure. [22] In addition to implantable cardioverter-defibrillators, several medications (stated above) reduce mortality in left heart failure and initiation of therapy should be as soon as indicated."}
{"id": "article-24161_23", "title": "Left Ventricular Failure -- Deterrence and Patient Education", "content": "Compliance with lifestyle modification and pharmacologic treatment and control of precipitating factors (like hypertension and arrhythmias)\u00a0are crucial to prevent hospitalizations for heart failure exacerbation and improve the quality of life. Many of those precipitating factors are potentially under patient control. That is why patient education is an integral part of a multidisciplinary approach to decrease mortality and morbidity due to heart failure.", "contents": "Left Ventricular Failure -- Deterrence and Patient Education. Compliance with lifestyle modification and pharmacologic treatment and control of precipitating factors (like hypertension and arrhythmias)\u00a0are crucial to prevent hospitalizations for heart failure exacerbation and improve the quality of life. Many of those precipitating factors are potentially under patient control. That is why patient education is an integral part of a multidisciplinary approach to decrease mortality and morbidity due to heart failure."}
{"id": "article-24161_24", "title": "Left Ventricular Failure -- Enhancing Healthcare Team Outcomes", "content": "an interprofessional approach is crucial in patients with advanced heart failure with an increased risk of readmissions. [16] [23] In a systematic review of 29 randomized controlled trials, an interprofessional approach decreased heart-failure related hospital admissions by 27%\u00a0and all-cause mortality by around 25%. This approach was also cost-effective. Well-trained nurses are an integral part of this approach since heart failure clinics led by nurses and\u00a0in coordination with the patients' providers were very successful in enhancing patient outcome. In\u00a0addition\u00a0to the availability of heart failure clinics, training personnel in heart failure management and patient education are cornerstones to a successful an interprofessional approach. Telephone follow up reduced hospital readmissions due to heart failure but not mortality. [level II]", "contents": "Left Ventricular Failure -- Enhancing Healthcare Team Outcomes. an interprofessional approach is crucial in patients with advanced heart failure with an increased risk of readmissions. [16] [23] In a systematic review of 29 randomized controlled trials, an interprofessional approach decreased heart-failure related hospital admissions by 27%\u00a0and all-cause mortality by around 25%. This approach was also cost-effective. Well-trained nurses are an integral part of this approach since heart failure clinics led by nurses and\u00a0in coordination with the patients' providers were very successful in enhancing patient outcome. In\u00a0addition\u00a0to the availability of heart failure clinics, training personnel in heart failure management and patient education are cornerstones to a successful an interprofessional approach. Telephone follow up reduced hospital readmissions due to heart failure but not mortality. [level II]"}
{"id": "article-24161_25", "title": "Left Ventricular Failure -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Left Ventricular Failure -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}